Valganciclovir is given to some patients to prevent a viral infection known as cytomegalovirus (CMV).
The most common cause of viral infections in transplant patients are CMV (which stands for cytomegalovirus).
If you are particularly at risk of developing CMV infection after your transplant you will be started on Valganciclovir. Valganciclovir is available as a 450mg tablet. The dose of valganciclovir required may change depending on transplant kidney function so always make sure you are aware after each clinic appointment what dose you should be taking. The duration of treatment is between 3 months and 6 months after the transplant operation.
How to get more supply
This will be supplied by the hospital going forward. Please ensure you always have two weeks supply spare at home for emergencies. When you require more please tell your kidney transplant team at your clinic appointment. Should you be running short between clinic appointments, contact the kidney transplant pharmacist and leave a voicemail:
On Saturdays and Sundays, please contact the Renal Admission Unit (RAU):
Last reviewed: 24 March 2026